These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


118 related items for PubMed ID: 8665573

  • 1. Effects of ifosfamide on immunocompetent effector cells.
    Multhoff G, Botzler C, Allenbacher A, Issels R.
    Cancer Immunol Immunother; 1996 May; 42(4):251-4. PubMed ID: 8665573
    [Abstract] [Full Text] [Related]

  • 2. Differential effects of ifosfamide on the capacity of cytotoxic T lymphocytes and natural killer cells to lyse their target cells correlate with intracellular glutathione levels.
    Multhoff G, Meier T, Botzler C, Wiesnet M, Allenbacher A, Wilmanns W, Issels RD.
    Blood; 1995 Apr 15; 85(8):2124-31. PubMed ID: 7718883
    [Abstract] [Full Text] [Related]

  • 3. A comparison of the effects of ifosfamide vs. mafosfamide treatment on intracellular glutathione levels and immunological functions of immunocompetent lymphocyte subsets.
    Botzler C, Kis K, Issels R, Multhoff G.
    Exp Hematol; 1997 Apr 15; 25(4):338-44. PubMed ID: 9131009
    [Abstract] [Full Text] [Related]

  • 4. Differential effects of ifosfamide on dendritic cell-mediated stimulation of T cell interleukin-2 production, natural killer cell cytotoxicity and interferon-gamma production.
    Kuppner MC, Bleifuss E, Noessner E, Mocikat R, Hesler Cv, Mayerhofer C, Issels RD.
    Clin Exp Immunol; 2008 Sep 15; 153(3):429-38. PubMed ID: 18647323
    [Abstract] [Full Text] [Related]

  • 5. Ifosfamide impairs the allostimulatory capacity of human dendritic cells by intracellular glutathione depletion.
    Kuppner MC, Scharner A, Milani V, Von Hesler C, Tschop KE, Heinz O, Issels RD.
    Blood; 2003 Nov 15; 102(10):3668-74. PubMed ID: 12855564
    [Abstract] [Full Text] [Related]

  • 6. Ifosfamide induced depletion of glutathione in human peripheral blood lymphocytes and protection by mesna.
    Meier T, Allenbacher A, Mueller E, Multhoff G, Botzler C, Wiesnet M, Issels R.
    Anticancer Drugs; 1994 Aug 15; 5(4):403-9. PubMed ID: 7949243
    [Abstract] [Full Text] [Related]

  • 7. OK-432 and IL-2-augmented cytotoxicity of human natural killer cells and cytotoxic T lymphocytes at the clonal level.
    Gravekamp C, Vreugdenhil R, Bolhuis RL.
    FEMS Microbiol Immunol; 1988 Jan 15; 1(1):31-9. PubMed ID: 2978812
    [Abstract] [Full Text] [Related]

  • 8. Intravenous ifosfamide/mesna is associated with depletion of plasma thiols without depletion of leukocyte glutathione.
    Pendyala L, Creaven PJ, Schwartz G, Meropol NJ, Bolanowska-Higdon W, Zdanowicz J, Murphy M, Perez R.
    Clin Cancer Res; 2000 Apr 15; 6(4):1314-21. PubMed ID: 10778956
    [Abstract] [Full Text] [Related]

  • 9. Ifosfamide-based drug combinations: preclinical evaluation of drug interactions and translation into the clinic.
    Vanhoefer U, Schleucher N, Klaassen U, Seeber S, Harstrick A.
    Semin Oncol; 2000 Feb 15; 27(1 Suppl 1):8-13. PubMed ID: 10697038
    [Abstract] [Full Text] [Related]

  • 10. Inhibition of cytotoxic T lymphocyte and natural killer cell-mediated lysis by O,S,S,-trimethyl phosphorodithioate is at an early postrecognition step.
    Rodgers KE, Grayson MH, Ware CF.
    J Immunol; 1988 Jan 15; 140(2):564-70. PubMed ID: 3257244
    [Abstract] [Full Text] [Related]

  • 11. Modulation of natural killer (NK) receptors on NK (CD3-/CD56+), T (CD3+/CD56-) and NKT-like (CD3+/CD56+) cells after heart transplantation.
    Aguilar P, Mathieu CP, Clerc G, Ethevenot G, Fajraoui M, Mattei S, Faure GC, Bene MC.
    J Heart Lung Transplant; 2006 Feb 15; 25(2):200-5. PubMed ID: 16446221
    [Abstract] [Full Text] [Related]

  • 12. The human liver contains multiple populations of NK cells, T cells, and CD3+CD56+ natural T cells with distinct cytotoxic activities and Th1, Th2, and Th0 cytokine secretion patterns.
    Doherty DG, Norris S, Madrigal-Estebas L, McEntee G, Traynor O, Hegarty JE, O'Farrelly C.
    J Immunol; 1999 Aug 15; 163(4):2314-21. PubMed ID: 10438977
    [Abstract] [Full Text] [Related]

  • 13. Ifosfamide induced stress response in human lymphocytes.
    Issels RD, Meier TH, Müller E, Multhoff G, Wilmanns W.
    Mol Aspects Med; 1993 Aug 15; 14(3):281-6. PubMed ID: 8264344
    [Abstract] [Full Text] [Related]

  • 14. Comparison of primary human cytotoxic T-cell and natural killer cell responses reveal similar molecular requirements for lytic granule exocytosis but differences in cytokine production.
    Chiang SC, Theorell J, Entesarian M, Meeths M, Mastafa M, Al-Herz W, Frisk P, Gilmour KC, Ifversen M, Langenskiöld C, Machaczka M, Naqvi A, Payne J, Perez-Martinez A, Sabel M, Unal E, Unal S, Winiarski J, Nordenskjöld M, Ljunggren HG, Henter JI, Bryceson YT.
    Blood; 2013 Feb 21; 121(8):1345-56. PubMed ID: 23287865
    [Abstract] [Full Text] [Related]

  • 15. Dual-functional capability of CD3+CD56+ CIK cells, a T-cell subset that acquires NK function and retains TCR-mediated specific cytotoxicity.
    Pievani A, Borleri G, Pende D, Moretta L, Rambaldi A, Golay J, Introna M.
    Blood; 2011 Sep 22; 118(12):3301-10. PubMed ID: 21821703
    [Abstract] [Full Text] [Related]

  • 16. The natural killer cell-like lytic activity expressed by cytolytic T lymphocytes is associated with the expression of a novel function-associated molecule.
    Harris DT, Jaso-Friedmann L, Devlin RB, Koren HS, Evans DL.
    Scand J Immunol; 1992 Mar 22; 35(3):299-309. PubMed ID: 1531548
    [Abstract] [Full Text] [Related]

  • 17. Human natural killer cells and cytotoxic T lymphocytes require cell surface carbohydrate determinants for lytic function.
    Kornbluth J.
    Cell Immunol; 1985 Oct 15; 95(2):276-87. PubMed ID: 3876159
    [Abstract] [Full Text] [Related]

  • 18. Immunological effects of the orally administered neuraminidase inhibitor oseltamivir in influenza virus-infected and uninfected mice.
    Burger RA, Billingsley JL, Huffman JH, Bailey KW, Kim CU, Sidwell RW.
    Immunopharmacology; 2000 Apr 15; 47(1):45-52. PubMed ID: 10708809
    [Abstract] [Full Text] [Related]

  • 19. NK-lysin, a novel effector peptide of cytotoxic T and NK cells. Structure and cDNA cloning of the porcine form, induction by interleukin 2, antibacterial and antitumour activity.
    Andersson M, Gunne H, Agerberth B, Boman A, Bergman T, Sillard R, Jörnvall H, Mutt V, Olsson B, Wigzell H.
    EMBO J; 1995 Apr 18; 14(8):1615-25. PubMed ID: 7737114
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 6.